Maiken Keson-Brookes, CLO & Corporate Secretary at Rubius Therapeutics, Inc. (RUBY), sold 2,732 shares at $6.57 ($18K) on 2022-02-01, disclosed to the SEC on 2022-02-01.
Open-market sale of $18k RUBY by CLO & Corporate Secretary. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| MURA | SELL | 2025-03-05 | $9K | — | Filing → |
| MURA | SELL | 2024-12-26 | $8K | — | Filing → |
| MURA | SELL | 2024-07-18 | $7K | — | Filing → |